(Q34441859)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

review article

1 reference

title

Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

4

Charles P Quesenberry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

2

Natalia Udaltsova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Gary D Friedman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

James Chan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

published in

Cancer Causes & Control

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

1821-1835

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10552-009-9375-2

2 February 2020

exact match

0 references

cites work

Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Review of the epidemiological literature on antidepressant use and breast cancer risk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Cytostatic and cytotoxic effects of cyclooxygenase inhibitors and their synergy with docosahexaenoic acid on the growth of human skin melanoma A-375 cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

The in vitro effects of piroxicam and meloxicam on canine cell lines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Atorvastatin: a potential chemopreventive agent in bladder cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Antihypertensive drug use and the risk of prostate cancer (Canada)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

A review of cancer chemopreventive agents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Drug-associated cholelithiasis: a case of sulindac stone formation and the incorporation of sulindac metabolites into the gallstones

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Do antidepressants cause, promote, or inhibit cancers?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Marrow aplasia and sulindac

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Initial screening for carcinogenicity of commonly used drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Screening for possible drug carcinogenicity: second report of findings

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Sulindac-induced bone marrow toxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

A toxicological review of beta-adrenergic blockers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Enterohepatic circulation of sulindac and metabolites

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10552-009-9375-2

Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Breast cancer risk in a large cohort of female antidepressant medication users

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Photo-damage in Northern European renal transplant recipients is associated with use of calcium channel blockers

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Prescription medication use during pregnancy and risk of infant leukemia (United States).

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Calcium channel blockers, verapamil and cancer risk

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Repeated analysis of semen parameters in beagle dogs during a 2-year study with the HMG-CoA reductase inhibitor, atorvastatin

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Biliary secretion of sulindac and metabolites in man.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010483

Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials

27 October 2018

1 reference

12 December 2020

Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy

1 reference

12 December 2020

Aplastic anemia and acute leukemia: a possible relationship with sulindac therapy?

1 reference

12 December 2020

Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin

1 reference

12 December 2020

Psychotropic medication use and risk of epithelial ovarian cancer

1 reference

12 December 2020

10.1007/S10552-009-9375-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19582585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

PubMed publication ID

19582585

1 reference